Latest database descriptions

assess the prevalence, awareness, treatment and control of high blood pressure (BP) in three French areas

In the area of public health:
(1) To produce quality data to calculate health indicators for incidence, survival and prevalence.
(2) To participate in the French network of cancer registries (FRANCIM) and to collaborate with SPF and INCa as part of the national cancer surveillance programme.
(3) To work with local stakeholders at a regional level (ARS, Regional cancer network, screening sites) and to concentrate on the local use of the generated knowledge (SROS cancer research, assessment of requirements, initial and continuous training).
(4) To assess the impact of the disease on the population scale: prevalence, survival with or without the disease.

In the area of research:
(1) To learn about the distribution of therapeutic innovations throughout the population and its impact from a health and economic standpoint
(2) To assess the heterogeneity factors in the distribution of cancer treatment developments and their impact in terms of social health inequality in primary and secondary healthcare usage.
(3) To participate in studies initiated by others by providing them with local knowledge from the registry team and data collected in Tarn.

1 - To evaluate the incidence of cancer mortality (including lung and pleura cancers) in the ARDCO cohort based on work calendar and benign asbestos-related diseases (asbestosis, pleural plaques). 2 - Evaluation of the contribution of CT examinations, thoughts on examination periodicity. 3 - To assess the psychological impact of post-occupational medical surveillance of individuals exposed to asbestos 4 - To evaluate the role of co-exposures to other carcinogens with asbestos pollution in the risk of developing cancer 5 - To contribute to defining the populations at risk of lung cancer 6 - To contribute defining optimal methods for monitoring populations previously exposed to asbestos

Objectives of the registry in the area of public health (access to pre and postnatal diagnostics, monitoring, caring for patients, evaluation):
1) Determine the prevalence of esophageal atresia and of its various anatomical forms.
2) Study the geographical distribution of this malformation
3) Determine mortality at one year for this malformation
4) Evaluate the disparities in care and the changes between the different centers.

Objectives of the registry in the areas of therapy and research:
1) Evaluate if the percentage of antenatal diagnostic and the earliness in care vary in our country over the next few years.
2) Evaluate the effect of the prenatal diagnosis on prevalence.
3) Evaluate the modifications that appeared in the care for newborns having esophageal atresia and the influence of the latter on the future of the patients. Recent modifications in care: installation of a transanatomic sensor, early feeding, abandoning parenteral nutrition, could influence the change (duration of hospitalization, complications) and the future at 1 year.
4) Evaluate the short-term prognosis (surgical complications, duration of hospitalization, duration of reanimation, etc.).
5) Structure and harmonize the care for esophageal atresia across the national territory.